Cargando…

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition

Detalles Bibliográficos
Autores principales:	Baldi, Bruno Guedes, Radzikowska, Elzbieta, Cottin, Vincent, Dilling, Daniel F., Ataya, Ali, Carvalho, Carlos Roberto Ribeiro, Harari, Sergio, Koslow, Matthew, Grutters, Jan C., Inoue, Yoshikazu, Gupta, Nishant, Johnson, Simon R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Diffuse Lung Disease: Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687712/ https://www.ncbi.nlm.nih.gov/pubmed/34942174 http://dx.doi.org/10.1016/j.chest.2021.12.640

Ejemplares similares

Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis
por: Matthew, Brianna P., et al.
Publicado: (2021)

ELECTRONIC VAPE-ASSOCIATED LUNG INJURY: A UNIQUE PRESENTATION
por: Hawk, Fahad, et al.
Publicado: (2020)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

CHILDHOOD-ONSET INTERSTITIAL LUNG DISEASE: A RARE CASE OF IDIOPATHIC, NONSPECIFIC INTERSTITIAL PNEUMONIA IN A TEENAGER
por: Cerro, Giuliana, et al.
Publicado: (2020)

AN UNUSUAL PRESENTATION OF NONSPECIFIC INTERSTITIAL PNEUMONIA
por: Matta, Atul, et al.
Publicado: (2020)

NOT ALL ARDS IS COVID: THE RISK OF PREMATURE CLOSURE AND THE VALUE OF MULTIDISCIPLINARY DISCUSSION
por: VARGAS, JORGE, et al.
Publicado: (2021)

THE PERFECT STORM: DIFFUSE ALVEOLAR HEMORRHAGE AFTER SARS-COV-2 INFECTION
por: WANG, EDWARD, et al.
Publicado: (2021)

THINKING BEYOND COVID-19: A CASE OF KRATOM-INDUCED PNEUMONITIS
por: MINICH, CORBYN, et al.
Publicado: (2021)

PULMONARY ALVEOLAR PROTEINOSIS SUBMITTED A WHOLE LUNG LAVAGE AFTER COVID-19: A CASE REPORT
por: D'AMBROSIO, PAULA, et al.
Publicado: (2021)

COVID-19 VACCINE UPTAKE IN AN INTERSTITIAL LUNG DISEASE CLINIC
por: LEAHY, AMY, et al.
Publicado: (2021)

OUTCOMES IN PATIENTS WITH SARCOIDOSIS DIAGNOSED WITH COVID-19
por: NADEEM, OWAIS, et al.
Publicado: (2021)

A CASE OF STEROID RESPONSIVE SEVERE PNEUMONIA RELATED TO IMMUNE-LIKE RECONSTITUTION INFLAMMATORY RESPONSE 3 MONTHS AFTER RITUXIMAB THERAPY FOR PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTIONS
por: POURSHAHID, SEYEDMOHAMMAD, et al.
Publicado: (2021)

A CASE OF SEVERE HYPOXEMIA AND HEMOPTYSIS SECONDARY TO E-CIGARETTE AND VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN COVID-19 ERA
por: POLISETTY, LAKSHMI, et al.
Publicado: (2021)

ORGANIZING PNEUMONIA FOLLOWING COVID-19: A REPORT OF 8 CASES
por: BETHLEM, MARCOS, et al.
Publicado: (2021)

A CASE OF SEVERE E-CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN THE TIME OF COVID-19
por: WASSERMAN, EVAN, et al.
Publicado: (2021)

MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)

AGGRESSIVE AND RAPID NASCENT HONEY COMBING DURING ACUTE COVID-19 INFECTION: A CASE REPORT
por: JOSHI, V., et al.
Publicado: (2022)

A CASE REPORT OF COMPLICATIONS IN A SURVIVOR OF SEVERE COVID-19: PULMONARY FIBROSIS AND LONG-TERM SUPPLEMENTAL OXYGEN REQUIREMENT
por: YANAMADALA, A.
Publicado: (2022)

EXTENSION OF STEROID THERAPY FOR POST-COVID-19 FIBROTIC LUNG SEQUALAE
por: TOUMAN, A., et al.
Publicado: (2022)

ORGANIZING PNEUMONIA AS A SIDE EFFECT OF COVID-19 VACCINE
por: DADHWAL, R., et al.
Publicado: (2022)

PREDICTORS OF POST-COVID-19 PULMONARY FIBROSIS: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

DERMATOMYOSITIS AFTER COVID-19 PNEUMONIA
por: KHANAM, VERISHA, et al.
Publicado: (2022)

WITHDRAWN
Publicado: (2022)

PUTTING THE "SARS” IN "SARS-COVID-19": A CASE OF SARCOID-LIKE INFLAMMATORY REACTION AFTER COVID-19 VACCINATION
por: JAFRI, MUSTAFA HUS, et al.
Publicado: (2022)

COVID-19 PNEUMONIA AND PERICARDITIS IN A PATIENT WITH UNTREATED CYSTIC LUNG DISEASE
por: KOZLIK, ANN, et al.
Publicado: (2022)

COVID-19 VACCINE-RELATED PNEUMONITIS
por: TSENG, CHENGTIN, et al.
Publicado: (2022)

MULTISYSTEM SARCOIDOSIS ASSOCIATED WITH THE COVID-19 MRNA VACCINE
por: MITMA, ANGEL A, et al.
Publicado: (2022)

Essential Components of an Interstitial Lung Disease Clinic: Results From a Delphi Survey and Patient Focus Group Analysis
por: Graney, Bridget A., et al.
Publicado: (2021)

Diagnosing EVALI in the Time of COVID-19
por: Callahan, Sean J., et al.
Publicado: (2020)

Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
por: Wong, Alyson W., et al.
Publicado: (2020)

Sarcoidosis: An Occupational Disease?
por: Oliver, L. Christine, et al.
Publicado: (2021)

Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis
por: Drake, Wonder P., et al.
Publicado: (2021)

Diagnostic Performance of Electronic Nose Technology in Sarcoidosis
por: van der Sar, Iris G., et al.
Publicado: (2022)

Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study
por: Nolan, Claire M., et al.
Publicado: (2022)

Early Radiographic Progression of Scleroderma: Lung Disease Predicts Long-term Mortality
por: Volkmann, Elizabeth R., et al.
Publicado: (2022)

Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis
por: DeDent, Alison M., et al.
Publicado: (2022)

The Use of Genetic Information to Define Idiopathic Pulmonary Fibrosis in UK Biobank
por: Leavy, Olivia C., et al.
Publicado: (2023)

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
por: Rahaghi, Franck F., et al.
Publicado: (2022)

Patient and Physician Assessments of Clinical Status: A Mixed-methods Study of Interstitial Lung Disease
por: Grant-Orser, Amanda, et al.
Publicado: (2023)

Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative
por: Hunninghake, Gary M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ec43e1aq2i0l6mv1ceir1g8p0n